Cardiovascular disease – the silent killer in rheumatoid arthritis

By Kumar Namita   Armstrong David J  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 384-387

Royal College Of Physicians

Access to resources Recommend Favorite

Biomarkers for Radiographic Progression in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 2, 2015-01 ,pp. : 147-169

Bentham Science Publishers

Access to resources Recommend Favorite

Rheumatoid Arthritis: An Autoimmune Disease with Female Preponderance and Cardiovascular Risk Equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-01 ,pp. : 81-93

Bentham Science Publishers

Access to resources Recommend Favorite

Laboratory Biomarkers for Guiding Therapy with Methotrexate in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 2, 2015-01 ,pp. : 202-211

Bentham Science Publishers

Access to resources Recommend Favorite

Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 1, 2011-01 ,pp. : 21-26

Bentham Science Publishers

Access to resources Recommend Favorite